Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report? [Yahoo! Finance]
Halozyme Therapeutics, Inc. (HALO)
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
halozyme.com/investors/default.aspx
Company Research
Source: Yahoo! Finance
Will the recent positive trend continue leading up to its next earnings release, or is Halozyme Therapeutics due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Halozyme Q4 Earnings Match Estimates, Revenues Lag Halozyme delivered fourth-quarter 2023 adjusted earnings of 82 cents per share, which came in line with the Zacks Consensus Estimate. The company recorded earnings of 48 cents in the year-ago period. Total revenues increased 27% year over year to $230 million in the fourth quarter. The top line was driven by higher product sales and continued growth in demand for Xyosted, and higher royalty payments from J&J for subcutaneous Darzalex and Roche's Phesgo. Revenues, however, missed the Zacks Consensus Estimate of $235 million. Quarter in Detail Halozyme's top line comprises product sales, royalties and revenues u
Show less
Read more
Impact Snapshot
Event Time:
HALO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HALO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HALO alerts
High impacting Halozyme Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HALO
News
- Mahesh Krishnan Elected to Halozyme's Board of Directors [Yahoo! Finance]Yahoo! Finance
- Mahesh Krishnan Elected to Halozyme's Board of DirectorsPR Newswire
- Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]Yahoo! Finance
- Halozyme to Report First Quarter 2024 Financial and Operating Results [Yahoo! Finance]Yahoo! Finance
- Halozyme to Report First Quarter 2024 Financial and Operating ResultsPR Newswire
HALO
Earnings
- 2/20/24 - Beat
HALO
Sec Filings
- 4/26/24 - Form 8-K
- 4/25/24 - Form 3
- 4/17/24 - Form 4
- HALO's page on the SEC website